Viatris, Aurobindo, Cipla to make generics of GSK ViiV’s HIV drug (GSK) Finances March 30, 2023 [ad_1] Wirestock The United Nations-backed Medicines Patent Pool (MPP) signed agreements with Aurobindo, Cipla and Viatris (NASDAQ:VTRS) to provide generic…
Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket Finances February 28, 2022 [ad_1] Viatris Inc. VTRS, +4.38%, the corporate fashioned by the merger of Mylan and Pfizer Inc. PFE, +3.83% unit Upjohn…
